$271 Million is the total value of Artia Global Partners LP's 36 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
KYMR | Exit | KYMERA THERAPEUTICS INC | $0 | – | -30,000 | -100.0% | -0.28% | – |
Exit | MODERNA INCcall | $0 | – | -10,000 | -100.0% | -0.68% | – | |
RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -22,321 | -100.0% | -0.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NOVO-NORDISK A S | 4 | Q3 2023 | 25.8% |
MERCK & CO INC | 4 | Q3 2023 | 14.1% |
ARGENX SE | 4 | Q3 2023 | 12.3% |
LILLY ELI & CO | 4 | Q3 2023 | 14.5% |
ABBVIE INC | 4 | Q3 2023 | 5.6% |
ASTRAZENECA PLC | 4 | Q3 2023 | 5.4% |
SEAGEN INC | 4 | Q3 2023 | 4.5% |
BIOMARIN PHARMACEUTICAL INC | 4 | Q3 2023 | 4.3% |
NEUROCRINE BIOSCIENCES INC | 4 | Q3 2023 | 2.1% |
VERTEX PHARMACEUTICALS INC | 4 | Q3 2023 | 2.6% |
View Artia Global Partners LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
View Artia Global Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.